Genetic changes in contralateral bronchioloalveolar carcinomas of the lung

Oncology

Volumn 60, Issue 1, 2001, Pages 81-87

  Shin, Sang Won ^a,b,c   Breathnach, Oscar S ^a,b,c   Linnoila, R Ilona ^a   Williams, John ^d   Gillespie, John W ^a   Kelley, Michael J ^a,b,e   Johnson, Bruce E ^a,b,c,f  

^a NATIONAL CANCER INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d WALTER REED ARMY MEDICAL CENTER   (United States)

^e DUKE UNIVERSITY   (United States)

^f DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Bronchioloalveolar carcinoma; Clonality; K ras; Loss of Heterozygosity; p53

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER GENETICS; CHROMOSOME ARM; CLINICAL ARTICLE; CLONOGENESIS; COMPARATIVE STUDY; FEMALE; GENETIC HETEROGENEITY; HETEROZYGOSITY LOSS; HUMAN; LUNG ADENOCARCINOMA; LUNG ALVEOLUS CELL CARCINOMA; MALE; METASTASIS; MUTAGENESIS; ONCOGENE K RAS; PRIORITY JOURNAL; TUMOR RECURRENCE;

ADENOCARCINOMA, BRONCHIOLO-ALVEOLAR; CLONE CELLS; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; GENES, P53; GENES, RAS; HUMANS; LOSS OF HETEROZYGOSITY; LUNG NEOPLASMS; NEOPLASMS, SECOND PRIMARY; PNEUMONECTOMY; POLYMERASE CHAIN REACTION;

EID: 28244475971     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000055301     Document Type: Article

References (26)

1. Histological typing of lung and pleural tumours
2. The changing pattern of lung carcinoma
3. Rising incidence of bronchioloalveolar lung carcinoma and its unique clinicopathologic features
4. Bronchioloalveolar carcinoma
5. Clinical features of patients with stage IIIB and IV bronchioloalveolar carcinoma of the lung
6. Recurrence and survival following resection of bronchioloalveolar carcinoma of the lung - The Lung Cancer Study Group experience
7. Metastatic bronchioloalveolar carcinoma and metastatic adenocarcinoma of the lung: Comparison of clinical manifestations, chemotherapeutic responses, and prognosis
8. Molecular pathologic substaging in 244 stage I non-small-cell lung cancer patients: Clinical implications
9. Bronchioloalveolar carcinoma
10. The multifocality of bronchioloalveolar lung carcinoma: Evidence and implications of a multiclonal origin
11. The spectrum and significance of bronchioloalveolar carcinomas
12. Synchronous and metachronous lung carcinomas: Molecular evidence for multicentricity
13. Genetic evidence for an independent origin of multiple preneoplastic and neoplastic lung lesions
14. Mutations of the P53 tumor suppressor gene as clonal marker for multiple primary lung cancers
15. Unknown primary head and neck squamous cell carcinoma: Molecular identification of the site of origin
16. Clonal origin of epithelial ovarian carcinoma: Analysis by loss of heterozygosity, p53 mutation, and X-chromosome inactivation
17. Bronchioloalveolar adenocarcinoma of lung: Monoclonal origin for multifocal disease
18. Second lung cancers in patients after treatment for an initial lung cancer
19. Laser capture microdissection: Molecular analysis of tissue
20. Allelotyping demonstrates common and distinct patterns of chromosomal loss in human lung cancer types
21. Semiautomated assessment of loss of heterozygosity and replication error in tumors
22. p53 Mutations in lung tumors: Relationship to putative susceptibility markers for cancer
23. Multiple primary lung cancers
24. Recurrence of bronchioloalveolar carcinoma in transplanted lungs
25. Distinguishing second primary tumors from lung metastases in patients with head and neck squamous cell carcinoma